2m 2m 2m 2m 2m 2m 2m
VOR BIOPHARMA (VOR)
NASDAQ
$21.26-$0.16 (-0.72%)
Price as of Aug 03, 2026 7:57 PM EDT- $1.1BMarket Cap
- -49.27%1-Year Change
- BiotechnologyIndustry
VOR BIOPHARMA (VOR)
$21.26-$0.16 (-0.72%)
VOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.41 | ||
Change | +$0.26 (+1.23%) | ||
Open | $20.97 | ||
High | $21.97 | ||
Low | $20.17 | ||
Previous Close | $21.15 | ||
Volume | 851,887 | ||
30-Day Average Volume | 1,099,288 | ||
1-Week Change | 10.13% | ||
1-Month Change | 3.98% | ||
1-Year Change | -49.27% | ||
3-Year Change | -62.96% | ||
5-Year Change | -91.26% | ||
Fundamentals | |||
Shares Outstanding | 54.2M | ||
Total Assets | $506.7M | ||
Market Cap | $1.1B | ||
Enterprise Value | $976.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$219.6M | ||
Free Cash Flow | -$38.3M | ||
EBIT | -$219.6M | ||
EBITDA | -$219.6M | ||
Net Working Capital | $484.7M | ||
EPS | -$5.11 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -8 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue